Lunt, M. J., Jenkinson, D. F. and Kerr, D., 2000. Transcranial Doppler blood velocity measurement-the effect of changes in velocity profile. Ultrasound in Medicine and Biology, 26 (7), pp. 1145-1151.
Full text not available from this repository.
Official URL: http://www.sciencedirect.com/science?_ob=ArticleUR...
Transcranial Doppler (TCD) units measure blood velocity in the middle cerebral artery (MCA) and are used to examine the effects of pharmacological agents. The units actually measure the average of the maximum blood velocity envelope (aveVmax) and it is assumed that changes in aveVmax follow changes in the true mean velocity (aveVmean). This may not be true if there are changes in velocity profile. Results from previous TCD studies using acetazolamide (ACZ) and caffeine were examined for evidence for changes in velocity profile. ACZ increased aveVmax by 21% (95% CI 13 to 29%) and aveVmean by 14% (95% CI 9 to 19%). Caffeine decreased aveVmax by 8% (95% CI 4 to 12%) and aveVmean by 5% (95% CI 4% increase to 13% decrease). In both cases, the true change, measured using aveVmean was lower, indicating possible changes in velocity profile. We conclude that the possibility of changes in velocity profile must be considered when using TCD to quantify changes in blood velocity.
|Uncontrolled Keywords:||Transcranial Doppler; Cerebral reactivity; Cerebral blood flow velocity; Caffeine; Acetazolamide|
|Subjects:||Technology > Medicine and Health > Medicine and Surgery|
|Group:||School of Health and Social Care > Centre for Postgraduate Medical Research and Education|
|Deposited By:||Ms MJ Bowden|
|Deposited On:||15 Feb 2008 16:05|
|Last Modified:||07 Mar 2013 14:46|
|Repository Staff Only -|
|BU Staff Only -|
|Help Guide -||Editing Your Items in BURO|